IP Verse

Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist

Patent No. EP3335707 (titled "Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist") was filed by Glaxo Group on Nov 29, 2010. The application was issued on Apr 17, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
AERAJan 17, 2025AERA
AERAJan 17, 2025BARDEHLE PAGENBERG SL
GENERICS UKJan 17, 2025ELKINGTON AND FIFE
KILBURN & STRODEJan 17, 2025KILBURN & STRODE
SANDOZJan 17, 2025MAIWALD
TEVA PHARMACEUTICALSJan 17, 2025ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3335707

GLAXO GROUP
Application Number
EP17206132A
Filing Date
Nov 29, 2010
Status
Revoked
Sep 19, 2025
Publication Date
Apr 17, 2024
External Links
Slate, Register , Google Patents